InterviewsJuly 16, 2021 Jackie von Salm: On Raising $2.5 million at Psilera to Further Cutting Edge Psychedelic Research
PressJuly 15, 2021 Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc
PressJuly 15, 2021 Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction
PressJuly 14, 2021 Clearmind Announces Changes To Senior Management As It Accelerates Development Of Its IP Portfolio
PressJuly 14, 2021 Red Light Holland Sells ~350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs
PressJuly 6, 2021 Seelos Therapeutics Doses First Patient in a Study of Intranasal Ketamine for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder
PressJuly 5, 2021 Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
PressJuly 5, 2021 COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research.
PressJuly 2, 2021 Osmind Closes $15 Million Series A Round to Help Clinicians and Researchers Bring Innovative Mental Health Treatments to More Patients
PressJune 23, 2021 Psychedelics Biotech Company, Awakn Life Sciences, Goes Public on the NEO Exchange
PressJune 22, 2021 Red Light Holland to Partner with Leading Fresh and Dried Mushroom Producers on East Coast Facility
